RLMD
Relmada Therapeutics Inc
3.60$
-1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -13.2% | -16.2% | -13.0% | +10.4% | -15.6% | -33.3% | -22.5% | +3.9% | -11.0% | +13.2% | -148.8% | – | |
| – | – | -88.9% | -537.0% | – | – | -264.3% | – | +18,838.4% | -73.9% | -116.2% | – | – | |
| – | – | -50.0% | +150.0% | -100.0% | – | -25.0% | +33.3% | -100.0% | – | – | – | – | |
| – | +100.5% | +29.9% | +39.3% | +15.2% | -29.7% | +35.4% | -56.5% | +1.1% | -1,239.2% | +75.8% | – | – | |
| – | – | – | -100.0% | – | +92.5% | -100.0% | – | -100.0% | – | +67.2% | -104.1% | – | |
| – | – | – | – | -180.2% | – | -214.1% | – | -84.7% | +6,684.0% | +197.3% | -75.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.